Search Results - "Abrate, Paolo"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Safety and Effectiveness of Multiple Switching Between Originators and Biosimilars: Literature Review and Status Report on Interchangeability by Lasala, Ruggero, Abrate, Paolo, Zovi, Andrea, Santoleri, Fiorenzo

    “…To date, numerous biosimilars are available in Europe and the practice of switching between originator and biosimilar or between two different biosimilars has…”
    Get more information
    Journal Article
  2. 2

    Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma by Lasala, Ruggero, Santoleri, Fiorenzo, Romagnoli, Alessia, Musicco, Felice, Abrate, Paolo, Costantini, Alberto

    Published in Journal of oncology pharmacy practice (01-06-2022)
    “…Introduction Pivotal Randomized Controlled Trials (RCTs) constitute scientific evidence in support of therapeutic choices when a drug is authorized in the…”
    Get full text
    Journal Article
  3. 3

    Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016 by Lasala, Ruggero, Santoleri, Fiorenzo, Zanon, Davide, Romagnoli, Alessia, Abrate, Paolo, Costantini, Alberto, Musicco, Felice

    Published in Journal of oncology pharmacy practice (01-01-2023)
    “…Background The treatment options available to children with cancer are limited. This is why for more than 10 years, the European Medicine Agency (EMA) has…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs by Lasala, Ruggero, Santoleri, Fiorenzo, Romagnoli, Alessia, Abrate, Paolo, Musicco, Felice, Costantini, Alberto

    “…ObjectivesTo assess how and to what extent adherence to medication is reported in pivotal clinical trials of oral cancer drugs.MethodsAll drugs authorised by…”
    Get full text
    Journal Article
  7. 7
  8. 8